The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-β (Aβ) deposition, tau hyperphosphorylation, oxidative stress, and chronic neuroinflammation. Growing evidence highlights neuroinflammation—driven by microglial activation and pro-inflamm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Joanna Kruszka, Jakub Martyński, Karolina Szewczyk-Golec, Alina Woźniak, Jarosław Nuszkiewicz
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Brain Sciences
Subjects:	Alzheimer’s disease amyloid-β cognitive function flavonoids neuroinflammation neuroprotection
Online Access:	https://www.mdpi.com/2076-3425/15/5/485
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Sleep disorders and Alzheimer’s disease: relationship and mechanisms involving neuroinflammation, orexin and Aβ
by: Wenjing Zhang, et al.
Published: (2025-06-01)

Computational discovery of plant-derived flavonoids as potential amyloid-β fibril disaggregating agents for alzheimer’s disease
by: Uthirapathi Logeswari Rakesh, et al.
Published: (2025-06-01)

Central Insulin-like Growth Factor-1 Treatment Enhances Working and Reference Memory by Reducing Neuroinflammation and Amyloid Beta Deposition in a Rat Model of Sporadic Alzheimer’s Disease
by: Joanna Dunacka, et al.
Published: (2025-04-01)

The role of monocytes and macrophages in the progression of Alzheimer’s disease
by: Wenyi Nie, et al.
Published: (2025-04-01)

Alzheimer’s Disease in the Age of Precision Medicine: Advances in Pathophysiology, Clinical Management and Therapeutic Strategies
by: Michał Piotrowski, et al.
Published: (2025-04-01)

The role of neuroinflammation in cerebral amyloid angiopathy
by: Hilde van den Brink, et al.
Published: (2024-12-01)

Effect of Artesunate on Behavioral Functions in Experimental Model of Alzheimer’s Disease
by: Chaitali Pattanayak, et al.
Published: (2025-01-01)

Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
by: Chenyu Zhuang, et al.
Published: (2025-03-01)

Interplay Between Aging and Tau Pathology in Alzheimer’s Disease: Mechanisms and Translational Perspectives
by: Mohammed Alrouji, et al.
Published: (2025-06-01)

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
by: Dan Chen, et al.
Published: (2025-01-01)

Maresin-like 1 Ameliorates Neuropathology of Alzheimer’s Disease in Brains of a Transgenic Mouse Model
by: Pallavi Shrivastava, et al.
Published: (2024-12-01)

Neuroprotective potential of quercetin in Alzheimer’s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-β aggregation
by: Mohd Adnan, et al.
Published: (2025-06-01)

Inflammasome-Mediated Neuroinflammation: A Key Driver in Alzheimer’s Disease Pathogenesis
by: Julie McGroarty, et al.
Published: (2025-05-01)

Gentiacaulein inhibits glucose transport to induce PRKAA1-mediated autophagy to clear amyloid beta and associated inflammation in primary astrocytes
by: Ankita Sharma, et al.
Published: (2024-12-01)

Sesamol Inhibits Aβ1-42-Induced Ferroptosis by Regulating the SLC7A11/GPX4/ACSL4 Axis in PC12 Cells
by: ZHAO Peijun, WANG Tianlin, XIE Shanshan, SONG Lianjun, HUANG Xianqing, LI Tiange
Published: (2025-05-01)

The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease
by: Xueyan Liu, et al.
Published: (2025-11-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Reevaluating the role of amyloid β-peptides in Alzheimer’s disease: from pathogenic agents to protective chelation mechanisms
by: Franco Cavaleri
Published: (2025-03-01)

The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer’s disease
by: Xiaowen Sun, et al.
Published: (2025-06-01)

Beyond Amyloid and Tau: The Critical Role of Microglia in Alzheimer’s Disease Therapeutics
by: Daniela Dias, et al.
Published: (2025-01-01)

A Review Article on Oxidative Stress Markers F2-Isoprostanes and Presenilin-1 in Alzheimer’s Disease
by: Dilip Raj Timalsina, et al.
Published: (2025-05-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

The dual role of microglia in Alzheimer’s disease: from immune regulation to pathological progression
by: Cong He, et al.
Published: (2025-03-01)

Editorial: Neuroinflammation and neurodegenerative diseases
by: Pradeep Kumar, et al.
Published: (2025-02-01)

Moss Extracts as Natural Neuroprotective Agents: Mitigating LPS-Induced Neuroinflammation and Microglial Activation
by: Tijana D. Stojanović, et al.
Published: (2025-05-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Autophagy in alzheimer disease pathogenesis and its therapeutic values
by: Gabrielle Angst, et al.
Published: (2025-12-01)

Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer’s disease: a focus on signaling mechanisms
by: Jingnan Han, et al.
Published: (2025-04-01)

The roles of microglia and astrocytes in neuroinflammation of Alzheimer’s disease
by: Jialin Han, et al.
Published: (2025-05-01)

Neuroinflammation and nutrition in Alzheimer’s disease
by: Hyoungshin Park, et al.
Published: (2025-07-01)

Korean traditional herbal formula Soshiho-tang attenuates memory impairment and neuronal damage in mice with amyloid-beta-induced Alzheimer's disease
by: Eunjin Sohn, et al.
Published: (2021-09-01)

Murine Non-Transgenic Models of Alzheimer’s Disease Pathology: Focus on Risk Factors
by: Maricarmen Hernández-Rodríguez, et al.
Published: (2025-03-01)

The effects of a bioavailable curcumin formulation on Alzheimer's disease pathologies: A potential risk for neuroinflammation
by: Shaun Cade, et al.
Published: (2024-12-01)

Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01)

Microglia efferocytosis: an emerging mechanism for the resolution of neuroinflammation in Alzheimer’s disease
by: Yongping Chen, et al.
Published: (2025-03-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Lecanemab for mild Alzheimer disease – is there a way forward?
by: Rajesh R Tampi
Published: (2025-03-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)